Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials

Christopher R. King, Debra Freeman, Irving Kaplan et al. · Radiotherapy and Oncology · 2013 · 460 citations · Full text

Medicine, Radiation Oncology, Urology +16

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

Amar U. Kishan, Audrey Dang, Alan J. Katz et al. · JAMA Network Open · 2019 · 314 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intrafractional Motion of the Prostate During Hypofractionated Radiotherapy

Yaoqin Xie, David Djajaputra, Christopher King et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 206 citations · Full text

Medicine, Radiation Oncology, Urology +14

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

Curtis Bryant, Tamara L. Smith, Randal H. Henderson et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 113 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study

Alan J. Katz, Josephine Kang · Frontiers in Oncology · 2014 · 105 citations · Full text

Medicine, Radiation Oncology, Urology +17